CoChat

The importance of propargylamine moiety in the anti‐ Parkinson drug rasagiline and its derivatives for MAPK‐ dependent amyloid precursor protein processing

Yogev-Falach, Merav, Amit, Tamar, Bar-Am, Orit, Youdim, Moussa B.H. · 2003 · The FASEB Journal
Cited by 118

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Rasagiline [N‐propargyl‐(1R)‐aminoindan] a highly potent selective irreversible monoamine oxidase (MAO)‐B inhibitor exerts neuroprotective and antiapoptotic effects against a variety of insults in cell cultures and in vivo and has finished its phase III clinical trials for Parkinson‘s disease. In the present study, we show that rasagiline (1 and 10 μM) significantly protected rat PC12 cells against β‐amyloid (Aβ 1‐42 ) toxicity. In addition, rasagiline significantly increased (approximately threefold) the secretion of the nonamyloidogenic soluble form of the amyloid precursor protein (sAPPα) from SH‐SY5Y neuroblastoma and PC12 cells. The increase of sAPPα was dose‐dependent and was blocked by the hydroxamic acid‐based metalloprotease inhibitor Ro31‐9790 (100 μM), suggesting that the effect is mediated via α‐secretase activity. Rasagiline‐induced sAPPα release was significantly reduced by the inhibitors of protein kinase C (PKC), GF109203X, and ERK mitogen‐activated protein kinase (MAPK) PD98059. Moreover, rasagiline dose dependently (0.1−10 μM) increased the phosphorylation of p44 and p42 MAPK, which was abolished by PD98059 (30 μM) and GF109203X (2.5 μM). By comparing the actions of rasagiline with those of its S‐isomer TVP1022, which is not an MAO inhibitor, we have been able to demonstrate that MAO‐B inhibition is not a prerequisite for either sAPPα‐induced release or ERK phosphorylation. In addition, structure‐activity relationship among rasagiline‐related compounds suggests the crucial role of the propargyl moiety in these molecules, because propargylamine itself significantly induced the secretion of sAPPα and increased MAPK phosphorylation with similar potency to that of rasagiline and its derivatives.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1096/fj.03-0078fje

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 118

Metadata

Authors
Yogev-Falach, M., Amit, T., Bar-Am, O., & Youdim, M. B. H.
Venue
The FASEB Journal
Publisher
Wiley
Published
2003-10-02
Volume
17
Issue
15
Pages
2325-2327
ISSN
  • 0892-6638 (ISSN-L)
  • 1530-6860
OpenAlex
W2107095942
Cited by
118
References
3
FWCI
5.79
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.